Skip to main content

Table 5 Comparison of MAP and HR at each time point among the three groups

From: Efficacy and safety of ciprofol for gastroscopy in patients with obesity: a randomised clinical controlled trial using different weight-based dosing scales

  

T0

T1

T2

T3

T4

T5

MAP

(mmHg)

Group T

(n = 36)

104.69 ± 11.66

92.47 ± 11.95a

90.22 ± 14.43a

87.91 ± 15.45a

92.21 ± 13.47a

93.79 ± 11.95a

Group I

(n = 38)

108.97 ± 9.16

95.19 ± 10.94ab

94.90 ± 13.22ab

89.39 ± 9.11a

91.45 ± 7.64a

92.52 ± 7.46a

Group L

(n = 34)

106.11 ± 14.17

94.17 ± 12.22ab

92.65 ± 10.48a

88.10 ± 10.80a

91.10 ± 12.57a

92.55 ± 9.92a

 

P value

0.283

0.598

0.356

0.336

0.905

0.825

HR

(beats/min)

Group T

(n = 36)

73.28 ± 11.46

71.31 ± 12.18

70.11 ± 12.11

68.50 ± 11.21

68.61 ± 10.59

69.50 ± 11.25

 

Group I

(n = 38)

71.84 ± 12.55

70.97 ± 11.48

71.84 ± 10.35

69.00 ± 9.15

69.03 ± 8.56

71.45 ± 7.88

 

Group L

(n = 34)

75.44 ± 13.10

71.82 ± 12.43

71.65 ± 12.10

69.82 ± 10.11

71.26 ± 10.77

71.26 ± 11.40

 

P value

0.468

0.956

0.783

0.988

0.788

0.683

  1. Note: Data are presented as mean ± standard deviation (mmHg or beats/min). Data were analysed using analysis of variance for comparisons between groups, and the least significant difference test was used for pairwise comparisons. If the assumption of homogeneity of variance was not satisfied, Welch analysis of variance was used for pairwise comparisons between the groups. Data within the groups were compared using repeated-measures analysis of variance. Each time point was defined as follows: T0, upon entry into the room (basal); T1, following anaesthesia induction; T2, upon insertion of the endoscope; T3, upon endoscope exit from the pharyngeal cavity; T4, during full patient awakening; and T5, at discharge from the hospital
  2. Abbreviations: MAP, mean arterial pressure; HR, heart rate
  3. *P < 0.05
  4. aP<0.05, compared to T0
  5. bP<0.05, compared to T3